| Name | Title | Contact Details |
|---|
Manchester Memorial Hospital is a Manchester, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Veyo is the next generation of healthcare logistics. Our mobile and cloud-based technologies are at the heart of what we do. Real-time dashboards, supply and demand analytics, and passenger and driver apps allow us to bring next-gen transportation to the healthcare industry. At Veyo, we believe transportation should be an ally to healthcare outcomes, not a barrier. Veyo is revolutionizing NEMT with a technology-first approach to patient transportation. Built for the healthcare industry and designed for the broad needs of health plan memberships, our end-to-end solution offers unmatched service quality, transparency, and efficiencies for all regions and all modes.
Cook Children`s Health Care System embraces an inspiring Promise – to improve the health of every child in our region through the prevention and treatment of illness, disease and injury. Based in Fort Worth, Texas, we`re proud of our long and rich tradition of serving our community.
Gardens Regional Hospital and Medical Center formerly doing business as Tri-City Regional Medical Center was recognized in 2012 by Consumer Reports Magazine, ranking as one of the top five safest hospitals in the Los Angeles Metropolitan area. In addition, the hospital was ranked number two in the U.S. for the lowest mortality rate for patients with pneumonia by Becker`s Hospital Review Magazine based on data from the Centers for Medicaid and Medicare Services (CMS).
Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.